Home
Storia in 1 fonti
Cancer Stock Breaks Out To Highs; Key FDA Action On Watch
Cancer treatment name Exelixis is attempting to clear a flat base with a pivot at 57.57 after second-quarter earnings.
Raccontata da
investors.com
Timeline cronologica
- ·
Cancer Stock Breaks Out To Highs; Key FDA Action On Watch
Cancer treatment name Exelixis is attempting to clear a flat base with a pivot at 57.57 after second-quarter earnings.
- ·
Stock Of The Day Hits Earnings Snag — And Then Breaks Out
Exelixis is Friday's IBD Stock Of The Day. Shares have recovered from a post June-quarter drop and are trading in a buy zone.